Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clopidogrel Pre-treatment in Elective PCI
NCT00421252Phase 4Terminated
- Sponsor
- Beth Israel Deaconess Medical Center
- Start
- Jan 2007
- Primary completion
- Nov 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of clopidogrel in coronary artery disease (CAD), sponsored by Beth Israel Deaconess Medical Center. Started Jan 2007; status: terminated.
02
Drugs
clopidogrel
03
Conditions
coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT00421252.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00421252.